Cytokinetics Inc. vs Johnson & Johnson
CYTK vs JNJ — side-by-side comparison from reported financials. CYTK leads 1, JNJ leads 7 of 8 comparable metrics.
Cytokinetics Inc.
CYTK · Healthcare
$62.91+1.45%Strained
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | CYTK | JNJ |
|---|---|---|
| Price | $62.91 | $261.79 |
| Market cap | $8.75B | $631B |
| Revenue (TTM) | $67.7M | $97.9B |
| Revenue growth | -2.4% | +5.6% |
| Net margin | -1321.3% | 21.5% |
| Free cash flow | -$581M | $22.2B |
| Net cash (debt) | $636M | ($27.8B) |
| 1-year price return | +4.3% | +37.0% |
| P/E | — | 29.9 |
| P/E vs own history (cheap-side %) | — | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | -131% | 26% |
| CV checks passed | 3 of 9 | 10 of 9 |
| Employees | 673 | 140,800 |
Full résumé-style profiles: CYTK CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.